GeoVax Labs raises $2.3M in registered direct offering

GeoVax Labs Inc. (NASDAQ: GOVX) completed a registered direct offering on September 30, 2025, raising approximately $2.3 million in net proceeds after fees and expenses.

The company sold 3,968,256 shares of common stock at $0.63 per share through a placement agency agreement with Roth Capital Partners. In a concurrent private placement, GeoVax issued warrants to purchase 11,904,768 additional shares, with each share purchased in the offering accompanied by three warrants.

The warrants carry an exercise price of $0.63 per share and will become exercisable upon stockholder approval at a special meeting required under Nasdaq rules. Once approved, the warrants will expire five years from the approval date.

GeoVax stated it intends to use the proceeds to advance product candidates through research and technical development, manufacturing, clinical studies, capital expenditures and working capital.

Under the purchase agreement, the company agreed not to issue additional shares or convertible securities for 45 days after closing, with certain exceptions. GeoVax also committed to avoid variable rate transactions involving common stock or convertible securities for six months following the offering close, subject to specified exceptions.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Active options: AVGO MSTR PLTR SNDK SMCI NBIS MSFT META GOOGL NU NFLX ONDS